What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?

Abstract

Children with sickle cell disease (SCD) frequently present to hospital acutely unwell and are often exposed to diagnostic chest X-rays (CXRs). Little evidence exists to determine when CXRs are clinically useful. Using electronic hospital records, we audited CXR use in children aged 0-18 who presented to hospital over the past 10years in both an inpatient and emergency department setting. From a total of 915 first CXRs, only 28·2% of CXRs (n=258) had clinically significant findings that altered management or final diagnosis. Of these abnormalities, consolidation represented 52·3%, effusion 8·9%, cardiomegaly 8·4% and sickle cell-related bone changes 6·3%. Indications for CXR of respiratory distress (OR=3·74, 95% CI 2·28-6·13), hypoxia (OR=1·86, 95% CI 1·50-2·31) and cough (OR=1·64, 95% CI 1·33-2·02), were more likely to have significant CXR findings. Patients who had higher peak fever (38·4°C vs. 37·4°C, P=0·001), higher peak CRP (156·4 vs. 46·1, P<0·001) and higher WCC (20·2 vs. 13·6, P<0·001) were more likely to have clinically significant abnormalities on CXR. We found a decision tool using either hypoxia, cough, respiratory distress, T>38°C, CRP>50 or WCC>15×109 /l as indications for CXR, to have a sensitivity of 88% (with 95% CI 0·78-0·95) and specificity of 46% (95% CI 0·43-0·50) for clinically significant findings.